🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is the Phase 1/2 first-in-human, randomized, placebo-controlled, obser...
Status
Completed
Location
Clinical Research Atlanta
Start Date
2017-06-05
Trial ID
NCT03170609
Treatments Being Tested
This study will evaluate the tolerability and immunogenicity of administrat...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-21
Trial ID
NCT00988884
To evaluate safety and immunogenicity of 2 different HIV-1 peptide candidat...
Status
Completed
Location
Univ of Alabama at Birmingham
Start Date
TBD
Trial ID
NCT00000846
Treatments Being Tested
This is a 2-stage, phase 1/2, randomized, active-controlled, observer-blind...
Status
Completed
Location
Achieve Clinical Research LLC
Start Date
2017-10-12
Trial ID
NCT03313050
Treatments Being Tested
This Phase 1b will describe the safety and immunogenicity of 2 multivalent ...
Status
Completed
Location
Collaborative Neuroscience Network, LLC.
Start Date
2018-08-29
Trial ID
NCT03642847
The purpose of this study is to test the safety and immunogenicity of MVA-B...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02860650
Treatments Being Tested
This phase 2 clinical trial will evaluate the safety and immunogenicity of ...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Start Date
2022-03-30
Trial ID
NCT05289037
Treatments Being Tested
This study is designed to evaluate the immunogenicity and tolerability of 9...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-29
Trial ID
NCT01651949
Treatments Being Tested
The main goal of this trial is to evaluate the safety and immunogenicity of...
Status
Recruiting
Location
Nuvisan GmbH
Start Date
2026-08-19
Trial ID
NCT07758972
Treatments Being Tested
This study is a phase III clinical trial to evaluate the immunogenicity and...
Status
Active Not Recruiting
Location
Yizhou District Disease Prevention Control Center
Start Date
2022-11-04
Trial ID
NCT05759520
Treatments Being Tested